Post-PCI fatal bleeding in aspirin and clopidogrel hyper responder. Shifting from antiplatelet resistance to bleeding risk assessment?

International Journal of Cardiology

Volumn 138, Issue 2, 2010, Pages 212-213

  Cuisset, Thomas ^a,b   Frere, Corinne ^a,b   Quilici, Jacques ^a   Uhry, Sabrina ^a   Alessi, Marie Christine ^a,b   Bonnet, Jean Louis ^a  

^a TIMONE HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Acute Coronary Syndrome; Antiplatelet Response; Major Bleeding

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; CLOPIDOGREL; ENOXAPARIN; PRASUGREL;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; BLOOD CLOTTING PARAMETERS; BRAIN HEMORRHAGE; CASE REPORT; CORONARY STENT; DRUG RESISTANCE; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; ST SEGMENT ELEVATION; THROMBOCYTE AGGREGATION; TREATMENT RESPONSE;

ACUTE CORONARY SYNDROME; ASPIRIN; BLOOD PLATELETS; FATAL OUTCOME; FEMALE; HUMANS; INTRACRANIAL HEMORRHAGES; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RISK ASSESSMENT; RISK FACTORS; TICLOPIDINE;

EID: 73849102592     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.06.044     Document Type: Article

References (5)

1. Cuisset T., Frere C., Quilici J., et al. Benefit of a 600 mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST elevation Acute Coronary Syndrome undergoing coronary stenting. J Am Coll Cardiol 48 (2006) 1339-1345
2. Frere C., Cuisset T., Quilici J., et al. ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome. Thromb Haemost 98 (2007) 838-843
3. Wiviott S.D., Trenk D., Frelinger A.L., et al., PRINCIPLE-TIMI 44 Investigators. Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the prasugrel in comparison to clopidogrel for inhibition of platelet activation and aggregation-thrombolysis in myocardial infarction 44 trial. Circulation 116 25 (Dec 18 2007) 2923-2932
4. Wiviott S.D., Braunwald E., McCabe C.H., et al., the TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357 20 (Nov 15 2007) 2001-2015
5. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150